MDT - Medtronic Plc Stock Analysis
Medtronic Plc (MDT) is a publicly traded company listed on the NYSE. It operates in the Medical Devices industry, part of the broader Healthcare sector. The company has a market capitalization of 130.75B, generates annual revenue of 34.76B, and reports net income of 4.76B. As of the latest data, the stock is trading at 101.99 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (2.78%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.67), indicating current market sentiment. Institutional ownership is reported at 88.44%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 17.85%, trading within a 52-week range of 79.29 - 106.33.
MDT - Medtronic Plc
101.99
Analyst Consensus
Hold 3.67
MDT – Analyst Rating Summary
- Strong Buy: 7
- Buy: 13
- Hold: 18
- Sell: 1
- Strong Sell: 0
- Total Analysts: 39
| Index: | S&P 500 | P/E: | 27.55 | EPS (ttm): | 3.70 | Insider Own: | 0.07% | Shs Outstand: | 1.28B | Perf Week: | -2.89% |
| Market Cap: | 130.75B | Forward P/E: | 16.67 | EPS next Y: | 6.12 | Insider Trans: | -3.61% | Shs Float: | 1.28B | Perf Month: | 12.80% |
| Income(ttm): | 4.76B | PEG: | 4.52 | EPS next Q: | 1.34 | Inst Own: | 88.44% | Short Float: | 1.06% | Perf Quarter: | 9.78% |
| Revenue(ttm): | 34.76B | P/S: | 3.76 | EPS this Y: | 2.77% | Inst Trans: | 0.07% | Short Ratio: | 1.88 | Perf Half Y: | 17.23% |
| Book/sh: | 37.95 | P/B: | 2.69 | EPS next Y: | 8.41% | ROA: | 5.26% | Short Interest: | 13.53M | Perf Year: | 17.85% |
| Cash/sh: | 6.50 | P/C: | 15.70 | EPS next 5Y: | 6.09% | ROE: | 9.81% | 52W Range: | 79.29 - 106.33 | Perf YTD: | 27.68% |
| Dividend Est.: | 2.84 (2.78%) | P/FCF: | 25.12 | EPS past 3/5Y: | -1.03% 0.39% | ROIC: | 6.24% | 52W High: | 106.33 -4.08% | Beta: | 0.72 |
| Dividend TTM: | 2.82 (2.76%) | Quick Ratio: | 1.80 | Sales past 3/5Y: | 1.91% 3.01% | Gross Margin: | 59.95% | 52W Low: | 79.29 28.63% | Perf 5Y: | -11.00% |
| Dividend Ex-Date: | Sep 26, 2025 | Current Ratio: | 2.42 | EPS Y/Y TTM: | 13.15% | Oper. Margin: | 18.61% | RSI (14): | 61.42 | Volatility: | 1.41% 1.88% |
| Employees: | 95000 | Debt/Eq: | 0.60 | Sales Y/Y TTM: | 5.34% | Profit Margin: | 13.71% | Recom: | 2.15 | Target Price: | 111.12 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.57 | EPS Q/Q: | 8.10% | Payout: | 77.47% | Rel Volume: | 0.62 | Prev Close: | 101.97 |
| Sales Surprise: | 1.06% | EPS Surprise: | 3.49% | Sales Q/Q: | 6.64% | Earnings: | Nov 18 BMO | Avg Volume: | 7.20M | Price: | 101.99 |
| SMA20: | 2.79% | SMA50: | 5.75% | SMA200: | 12.43% | Undervalued: 8.95% | Volume: | 4,476,017 | Change: | 0.02% | |
Graham Classic formula value: 68.71
(P/E=8 * 1g) Min value: 46.81
(current P/E * 2g) Max value: 132.0
Average value: 82.51
About Medtronic Plc
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.